Indoco Remedies Limited (NSE:INDOCO) — Stock Price

Rs221.41 INR
▼ -0.14% today

Indoco Remedies Limited (NSE:INDOCO) is currently trading at Rs221.41 INR, down 0.14% today. Over the past 52 weeks, shares have ranged between Rs164.00 and Rs308.60. This page tracks Indoco Remedies Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Indoco Remedies Limited worth.

Indoco Remedies Limited (INDOCO) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Indoco Remedies Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Indoco Remedies Limited Income Statement — Revenue, Profit & Earnings by Year

Indoco Remedies Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs18.45 Billion Rs16.65 Billion Rs17.88 Billion Rs16.40 Billion Rs15.04 Billion
Cost of Revenue Rs10.94 Billion Rs10.06 Billion Rs11.85 Billion Rs5.39 Billion Rs4.80 Billion
Gross Profit Rs7.51 Billion Rs6.59 Billion Rs6.03 Billion Rs11.01 Billion Rs10.24 Billion
Research & Development Rs795.40 Million Rs760.10 Million Rs971.60 Million Rs809.70 Million Rs746.42 Million
SG&A — Rs3.94 Billion Rs367.60 Million Rs2.65 Billion Rs125.13 Million
Total Operating Expenses Rs7.36 Billion Rs6.73 Billion Rs4.75 Billion Rs9.03 Billion Rs8.21 Billion
Operating Income Rs153.50 Million Rs-145.80 Million Rs1.29 Billion Rs1.98 Billion Rs2.15 Billion
EBITDA Rs1.42 Billion Rs1.06 Billion Rs2.67 Billion Rs2.88 Billion Rs3.25 Billion
EBIT Rs153.50 Million Rs-81.40 Million Rs1.75 Billion Rs2.18 Billion Rs2.47 Billion
Interest Expense Rs1.22 Billion Rs662.30 Million Rs370.42 Million Rs247.86 Million Rs108.52 Million
Income Before Tax Rs-1.07 Billion Rs-743.70 Million Rs1.36 Billion Rs1.93 Billion Rs2.37 Billion
Income Tax Expense Rs-78.10 Million Rs35.80 Million Rs387.95 Million Rs505.50 Million Rs817.72 Million
Net Income Rs-987.00 Million Rs-737.40 Million Rs984.60 Million Rs1.42 Billion Rs1.55 Billion

Indoco Remedies Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Indoco Remedies Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs25.93 Billion Rs24.30 Billion Rs21.45 Billion Rs16.58 Billion Rs14.86 Billion
Total Current Assets Rs11.93 Billion Rs10.01 Billion Rs9.55 Billion Rs8.14 Billion Rs7.74 Billion
Cash & Equivalents — — — — —
Short-term Investments — Rs32.20 Million Rs72.44 Million Rs39.95 Million Rs241.50 Million
Net Receivables Rs4.94 Billion Rs3.56 Billion Rs4.34 Billion Rs3.62 Billion Rs2.99 Billion
Inventory Rs4.05 Billion Rs4.19 Billion Rs3.53 Billion Rs3.26 Billion Rs3.11 Billion
Property, Plant & Equipment — Rs11.25 Billion Rs8.91 Billion Rs6.68 Billion Rs5.85 Billion
Goodwill Rs215.20 Million Rs215.20 Million Rs215.20 Million Rs900.00K Rs900.00K
Total Liabilities Rs16.61 Billion Rs14.12 Billion Rs10.34 Billion Rs6.30 Billion Rs5.81 Billion
Total Current Liabilities Rs10.53 Billion Rs8.08 Billion Rs6.12 Billion Rs4.25 Billion Rs4.25 Billion
Long-term Debt — Rs5.33 Billion Rs3.52 Billion Rs1.44 Billion Rs958.80 Million
Net Debt Rs10.57 Billion Rs9.77 Billion Rs6.57 Billion Rs3.22 Billion Rs2.39 Billion
Total Stockholder Equity Rs9.39 Billion Rs10.22 Billion Rs11.10 Billion Rs10.28 Billion Rs9.05 Billion
Retained Earnings — Rs6.72 Billion Rs7.65 Billion Rs6.87 Billion Rs5.64 Billion

Indoco Remedies Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Indoco Remedies Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs324.30 Million Rs278.90 Million Rs1.55 Billion Rs1.79 Billion Rs1.74 Billion
Capital Expenditures Rs1.48 Billion Rs3.56 Billion Rs4.27 Billion Rs2.07 Billion Rs1.25 Billion
Free Cash Flow Rs-1.15 Billion Rs-3.28 Billion Rs-2.71 Billion Rs-284.30 Million Rs485.05 Million
Investing Cash Flow Rs-1.03 Billion Rs-3.44 Billion Rs-4.38 Billion Rs-2.08 Billion Rs-1.21 Billion
Financing Cash Flow Rs952.20 Million Rs3.09 Billion Rs3.19 Billion Rs228.10 Million Rs-443.72 Million
Dividends Paid Rs-19.10 Million Rs-139.00 Million Rs-207.06 Million Rs207.20 Million Rs137.93 Million
Stock-Based Compensation — Rs18.70 Million Rs28.80 Million Rs6.60 Million Rs0.00
Depreciation Rs1.26 Billion Rs1.14 Billion Rs918.65 Million Rs706.10 Million Rs772.09 Million
Change in Cash Rs159.24 Million Rs-65.32 Million Rs39.31 Million Rs-65.40 Million Rs80.48 Million

Indoco Remedies Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Indoco Remedies Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 20, 2026 — — —
Jan 19, 2026 — — —
Nov 06, 2025 -0.95 -3.00 +68.33%
Jul 21, 2025 — — —
May 22, 2025 -4.48 -3.60 -24.44%
Jan 21, 2025 -2.96 -2.40 -23.33%
Oct 24, 2024 -1.08 2.40 -145.00%
Jul 23, 2024 0.20 2.90 -93.10%